{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:03:55Z","timestamp":1789038235812,"version":"build-2803163510"},"reference-count":82,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1084706"],"award-info":[{"award-number":["1084706"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C virus (HCV) can be cleared naturally in a subset of individuals. However, the asymptomatic nature of acute HCV infection makes the study of the early immune response and defining the correlates of protection challenging. Despite this, there is now strong evidence implicating the humoral immune response, specifically neutralising antibodies, in determining the clearance or chronicity outcomes of primary HCV infection. In general, immunoglobulin G (IgG) plays the major role in viral neutralisation. However, there are limited investigations of anti-HCV envelope protein 2 (E2) isotypes (IgM, IgG, IgA) and IgG subclasses (IgG1\u20134) in early HCV infection. In this study, using a rare cohort of 14 very recently HCV-infected individuals (4\u201345 days) with varying disease outcome (n = 7 clearers), the timing and potency of anti-HCV E2 isotypes and IgG subclasses were examined longitudinally, in relation to neutralising antibody activity. Clearance was associated with anti-E2 IgG, specifically IgG1 and IgG3, and appeared essential to prevent the emergence of new HCV variants and the chronic infection outcome. Interestingly, these IgG responses were accompanied by IgM antibodies and were associated with neutralising antibody activity in the subjects who cleared infection. These findings provide novel insights into the early humoral immune response characteristics associated with HCV disease outcome.<\/jats:p>","DOI":"10.3390\/v12010075","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T03:07:11Z","timestamp":1578539231000},"page":"75","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-9880","authenticated-orcid":false,"given":"Melanie R.","family":"Walker","sequence":"first","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auda A.","family":"Eltahla","sequence":"additional","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Mina","sequence":"additional","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-8887","authenticated-orcid":false,"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-3744","authenticated-orcid":false,"given":"Rowena A.","family":"Bull","sequence":"additional","affiliation":[{"name":"Viral Immunology Systems Program, The Kirby Institute, Sydney, NSW 2052, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis c: Global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","unstructured":"The Polaris Observatory HCV Collaborators (2017). Global prevalence and genotype distribution of hepatitis c virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol., 2, 161\u2013176."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF01719282","article-title":"Blood-borne virus infections among australian injecting drug users: Implications for spread of hiv","volume":"10","author":"Crofts","year":"1994","journal-title":"Eur. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyg101","article-title":"Modelling hepatitis c virus incidence, prevalence and long-term sequelae in australia, 2001","volume":"32","author":"Law","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cid\/cix768","article-title":"The effect of female sex on hepatitis c incidence among people who inject drugs: Results from the international multicohort inc3 collaborative","volume":"66","author":"Esmaeili","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","first-page":"S35","article-title":"Natural history of chronic hepatitis c","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis c infection: A systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J. Viral Hepat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/JCM.38.2.477-482.2000","article-title":"Simplified hepatitis c virus genotyping by heteroduplex mobility analysis","volume":"38","author":"White","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1746.1997.tb00404.x","article-title":"Hepatitis c virus genotypes in a cohort of australian blood donors and haemophiliac and liver transplant patients","volume":"12","author":"Chen","year":"1997","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2893.1997.00060.x","article-title":"Hepatitis c virus genotypes in australia","volume":"4","author":"McCaw","year":"1997","journal-title":"J. Viral Hepat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1440-1746.1998.tb00761.x","article-title":"Molecular epidemiology of hepatitis c in australia","volume":"13","author":"Kaba","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.23885","article-title":"Frequent multiple hepatitis c virus infections among injection drug users in a prison setting","volume":"52","author":"Pham","year":"2010","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/JCM.00287-16","article-title":"Incident hepatitis c virus genotype distribution and multiple infection in australian prisons","volume":"54","author":"Walker","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"Potential role for interleukin-28b genotype in treatment decision-making in recent hepatitis c virus infection","volume":"52","author":"Grebely","year":"2010","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis c virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis c infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis c","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis c virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49454-w","article-title":"Clearance of hepatitis c virus is associated with early and potent but narrowly-directed, envelope-specific antibodies","volume":"9","author":"Walker","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.vaccine.2008.04.067","article-title":"Cellular and humoral responses to tetanus vaccination in gabonese children","volume":"26","author":"Retra","year":"2008","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/JVI.75.14.6558-6565.2001","article-title":"Immunoglobulin g3 from polyclonal human immunodeficiency virus (hiv) immune globulin is more potent than other subclasses in neutralizing hiv type 1","volume":"75","author":"Scharf","year":"2001","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis c virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1993.tb05929.x","article-title":"Antigenic regions within the hepatitis c virus envelope 1 and non-structural proteins: Identification of an igg3-restricted recognition site with the envelope 1 protein","volume":"91","author":"Sallberg","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis c virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","first-page":"207","article-title":"Diagnosis of hcv related acute hepatitis by serial determination of igm to hcv: A preliminary observation","volume":"17","author":"Sagnelli","year":"2003","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4254\/wjh.v7.i10.1377","article-title":"Hepatitis c virus: Virology, diagnosis and treatment","volume":"7","author":"Li","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1073\/pnas.89.13.5971","article-title":"Transient immunoglobulin m antibody response to hepatitis c virus capsid antigen in posttransfusion hepatitis c: Putative serological marker for acute viral infection","volume":"89","author":"Chen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890440102","article-title":"Immunoglobulin m and a antibodies to hepatitis c core antigen in chronic hepatitis c virus infection","volume":"44","author":"Lau","year":"1994","journal-title":"J. Med. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1155\/2000\/248139","article-title":"Humoral immune response in japanese acute hepatitis patients with hepatitis c virus infection","volume":"14","author":"Yamaguchi","year":"2000","journal-title":"Can. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2893.2002.00369.x","article-title":"Virus-specific antibody titres in different phases of hepatitis c virus infection","volume":"9","author":"Nikolaeva","year":"2002","journal-title":"J. Viral Hepat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/archinte.1993.00410130110011","article-title":"Iga deficiency associated with chronic hepatitis c virus infection. A cause or an effect?","volume":"153","author":"Ilan","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF02065435","article-title":"Clinical study of iga antibody against hepatitis c virus core antigen in patients with type c chronic liver disease","volume":"40","author":"Tanaka","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/BF02088141","article-title":"Igm and iga antibodies generated against hepatitis c virus core antigen in patients with acute and chronic hcv infection","volume":"39","author":"Sato","year":"1994","journal-title":"Dig. Dis. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F5","DOI":"10.1097\/QAD.0000000000001857","article-title":"Anti-hiv igm protects against mucosal shiv transmission","volume":"32","author":"Gong","year":"2018","journal-title":"Aids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced igm in the protection against west nile virus infection","volume":"198","author":"Diamond","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.immuni.2016.06.014","article-title":"Somatically hypermutated plasmodium-specific igm(+) memory b cells are rapid, plastic, early responders upon malaria rechallenge","volume":"45","author":"Krishnamurty","year":"2016","journal-title":"Immunity"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chua, C.L., Sam, I.C., Chiam, C.W., and Chan, Y.F. (2017). The neutralizing role of igm during early chikungunya virus infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171989"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/CVI.00374-14","article-title":"Influenza virus-specific neutralizing igm antibodies persist for a lifetime","volume":"21","author":"Skountzou","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fimmu.2019.00945","article-title":"Functional roles of the igm fc receptor in the immune system","volume":"10","author":"Kubagawa","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vaccine.2009.09.086","article-title":"The smallpox vaccine induces an early neutralizing igm response","volume":"28","author":"McCausland","year":"2009","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/088922203769232584","article-title":"Binding and neutralization activity of human igg1 and igg3 from serum of hiv-infected individuals","volume":"19","author":"Cavacini","year":"2003","journal-title":"Aids Res. Hum. Retrovir."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an hiv-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ackerman, M.E., Mikhailova, A., Brown, E.P., Dowell, K.G., Walker, B.D., Bailey-Kellogg, C., Suscovich, T.J., and Alter, G. (2016). Polyfunctional hiv-specific antibody responses are associated with spontaneous hiv control. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005315"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/161.2.198","article-title":"Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers","volume":"161","author":"Ljunggren","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"228ra239","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced env v1-v2 igg3 correlates with lower hiv-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with alvac and aidsvax to prevent hiv-1 infection in thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma iga specific for the c1 region of the hiv-1 envelope blocks binding and effector function of igg","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., Kaldor, J., Dore, G.J., Dolan, K., and Ffrench, R. (2010). Incidence of primary hepatitis c infection and risk factors for transmission in an australian prisoner cohort. BMC Public Health, 10.","DOI":"10.1186\/1471-2458-10-633"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis c incidence in australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10654-009-9421-0","article-title":"Incidence and risk for acute hepatitis c infection during imprisonment in australia","volume":"25","author":"Dolan","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1246-7820(01)00125-2","article-title":"Insights into the epidemiology, natural history and pathogenesis of hepatitis c virus infection from studies of infected donors and blood product recipients","volume":"8","author":"Busch","year":"2001","journal-title":"Transfus Clin. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis c virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis c virus (hcv) infection and to project hcv incidence rates","volume":"46","author":"Pappalardo","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bull, R.A., Luciani, F., McElroy, K., Gaudieri, S., Pham, S.T., Chopra, A., Cameron, B., Maher, L., Dore, G.J., and White, P.A. (2011). Sequential bottlenecks drive viral evolution in early acute hepatitis c virus infection. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002243"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1586\/erm.10.101","article-title":"Hepatitis c virus rna assays: Current and emerging technologies and their clinical applications","volume":"11","author":"Azzazy","year":"2011","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"44218","DOI":"10.1074\/jbc.M111.290783","article-title":"Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis c virus","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e01668-16","DOI":"10.1128\/JVI.01668-16","article-title":"An optimized hepatitis c virus e2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry","volume":"91","author":"McCaffrey","year":"2017","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis c virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1128\/JVI.02070-15","article-title":"Monoclonal antibodies directed toward the hepatitis c virus glycoprotein e2 detect antigenic differences modulated by the n-terminal hypervariable region 1 (hvr1), hvr2, and intergenotypic variable region","volume":"89","author":"Alhammad","year":"2015","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/jmv.24010","article-title":"Dynamics of hcv rna levels during acute hepatitis c virus infection","volume":"86","author":"Hajarizadeh","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hajarizadeh, B., Grady, B., Page, K., Kim, A.Y., McGovern, B.H., Cox, A.L., Rice, T.M., Sacks-Davis, R., Bruneau, J., and Morris, M. (2015). Patterns of hepatitis c virus rna levels during acute infection: The inc3 study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122232"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2008.06.013","article-title":"Evaluation of an automated, highly sensitive, real-time pcr-based assay (cobas ampliprep\/cobas taqman) for quantification of hcv rna","volume":"43","author":"Sarrazin","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-0934(01)00433-5","article-title":"Quantitation of hepatitis c virus rna by third generation branched DNA-based signal amplification assay","volume":"101","author":"Ross","year":"2002","journal-title":"J. Virol. Methods"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1128\/IAI.67.11.5951-5957.1999","article-title":"Human onchocerciasis and tetanus vaccination: Impact on the postvaccination antitetanus antibody response","volume":"67","author":"Cooper","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional fc-effector profiles mediated by igg subclass selection distinguish rv144 and vax003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_67","first-page":"127","article-title":"Igg2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.21360","article-title":"Diverse igg subclass responses to adeno-associated virus infection and vector administration","volume":"81","author":"Murphy","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00705-011-1047-3","article-title":"Immunoglobulin g subclasses in antibody responses to st. Louis encephalitis virus infections","volume":"156","author":"Spinsanti","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/088922203322230969","article-title":"Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the v3 loop of hiv-1 gp120","volume":"19","author":"Liu","year":"2003","journal-title":"Aids Res. Hum. Retrovir."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/JVI.02155-10","article-title":"Human igg subclasses: In vitro neutralization of and in vivo protection against west nile virus","volume":"85","author":"Hofmeister","year":"2011","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2009.09.024","article-title":"Dengue virus neutralization is modulated by igg antibody subclass and fcgamma receptor subtype","volume":"394","author":"Rodrigo","year":"2009","journal-title":"Virology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2019.02.032","article-title":"Genomic characterization of hepatitis c virus transmitted founder variants with deep sequencing","volume":"71","author":"Abayasingam","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor frequency and affinity determine b cell competitive fitness in germinal centers, tested with germline-targeting hiv vaccine immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2015.11.005","article-title":"Virus-specific cd4+ t cells have functional and phenotypic characteristics of follicular t-helper cells in patients with acute and chronic hcv infections","volume":"150","author":"Raziorrouh","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/vim.2018.0010","article-title":"Interleukin-7 regulates t follicular helper cell function in patients with chronic hepatitis c","volume":"31","author":"Zhang","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jvh.12576","article-title":"Hepatitis c-specific effector and regulatory cd4 t-cell responses are associated with the outcomes of primary infection","volume":"23","author":"Keoshkerian","year":"2016","journal-title":"J. Viral Hepat."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sok, D., Laserson, U., Laserson, J., Liu, Y., Vigneault, F., Julien, J.P., Briney, B., Ramos, A., Saye, K.F., and Le, K. (2013). The effects of somatic hypermutation on neutralization and binding in the pgt121 family of broadly neutralizing hiv antibodies. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/f1f8c791-61e9-45c6-a455-92c6dadf9f06"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1073\/pnas.95.17.10089","article-title":"Targeted gene disruption reveals a role for natural secretory igm in the maturation of the primary immune response","volume":"95","author":"Ehrenstein","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/clin.1996.0175","article-title":"Serum and secretory iga from hiv-infected individuals mediate antibody-dependent cellular cytotoxicity","volume":"81","author":"Black","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2015.01.022","article-title":"Immune complexes: Not just an innocent bystander in chronic viral infection","volume":"42","author":"Wang","year":"2015","journal-title":"Immunity"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial b-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin m (igm) and igg antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/75\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:42:28Z","timestamp":1760362948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["v12010075"],"URL":"https:\/\/doi.org\/10.3390\/v12010075","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]}}}